M.Pharmacy; Responsible for Formulation Development of Nasal Formulations. Responsible for conducting Formulation Development Trials and documenting the details in LNB.
MSc, PhD, PharmD, or MD. experience in medical communications. Medical writing experience. Demonstrate a command of assigned therapeutic areas and expertise with assigned products.
M.Pharm or M.Sc in Biochemistry/ Biotechnology/ Microbiology/ Life Sciences. Towards discovery and development of novel drugs and pharmaceuticals Metastatic and Chemoresistant Breast Cancer Stem Cells
Responsible for Monitoring and Completion of the production batches as the scheduled timelines. Responsible for implementation of the cGMP practices in the area. Responsible for Indenting of the production process related accessories and consumables.
B.Pharm / M.Pharm / M.Sc. ; Handling of complex injectable products and peptide molecules analysis. Core competency to take care of CMO, CDMO products. Ownership on Testing and compliance.
A Prospective, Multicenter, Single-arm, Open-label, Phase IV, Post authorization Interventional Study to Assess the Safety and Efficacy of Asciminib in Indian Patients with Ph+ CML-CP without T315I Mutation, Previously Treated with two or more Tyrosine Kinase Inhibitors and Ph+ CML-CP with T315I Mutation
Making a positive impact on the well-being of human life has inspired every aspect of our work. Each day, we at VIMTA touch millions of lives across the globe with the same intent.
PhD, MD, MDS or equivalent degree OR MVSc, MPharm, ME, MTech, with three years of research, teaching and design and development experience, with at least one research paper in Science Citation Index journal
Deciphering Chromatin-mediated mechanisms of transcription regulation in Apicomplexan Parasite Theileria annulata. Post Graduate Degree in life sciences OR Post Graduate degree in professional course. M.V.Sc, M.Tech, MSc. Degree in Biotechnology Biochemistry, Microbiology, Immunology.